Cargando…
Maresin 1 Alleviates Diabetic Kidney Disease via LGR6-Mediated cAMP-SOD2-ROS Pathway
Background. Chronic hyperglycemia-induced inflammation is recognized as the most important pathophysiological process in diabetic kidney disease (DKD). As maresin 1 (MaR1) is an extensive anti-inflammatory lipid mediator, the present study investigated the protective role of MaR1 in the pathogenesis...
Autores principales: | Li, Xinyue, Xu, Butuo, Wu, Jing, Pu, Yueli, Wan, Shengrong, Zeng, Yan, Wang, Mei, Luo, Lifang, Zhang, Fanjie, Jiang, Zongzhe, Xu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042615/ https://www.ncbi.nlm.nih.gov/pubmed/35498124 http://dx.doi.org/10.1155/2022/7177889 |
Ejemplares similares
-
Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions
por: Chiang, Nan, et al.
Publicado: (2023) -
The Maresin 1–LGR6 axis decreases respiratory syncytial virus-induced lung inflammation
por: Krishnamoorthy, Nandini, et al.
Publicado: (2023) -
Mitochondrial cAMP signaling
por: Zhang, Fan, et al.
Publicado: (2016) -
Asprosin in the Paraventricular Nucleus Induces Sympathetic Activation and Pressor Responses via cAMP-Dependent ROS Production
por: Wang, Xiao-Li, et al.
Publicado: (2022) -
Maresin-1 and Inflammatory Disease
por: Saito-Sasaki, Natsuko, et al.
Publicado: (2022)